PHARMACEUTICAL FORMULATION FOR CONTROLLED RELEASE CONTAINING MIRABEGRON OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS AN ACTIVE INGREDIENT

PHARMACEUTICAL FORMULATION FOR CONTROLLED RELEASE CONTAINING MIRABEGRON OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS AN ACTIVE INGREDIENT

The present invention relates to a formulation for controlled release containing mirabegron or pharmaceutically acceptable salt thereof, isomalt, and a sustained release agent. Disclosed is the formulation in which a therapeutic effect can be constantly maintained during long-term storage since mira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KWON SEOKYOUNG, PARK YOUNSANG, HAN JONGKWON, KOO DAEHWAN
Format: Patent
Sprache:eng ; kor
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a formulation for controlled release containing mirabegron or pharmaceutically acceptable salt thereof, isomalt, and a sustained release agent. Disclosed is the formulation in which a therapeutic effect can be constantly maintained during long-term storage since mirabegron, which is a drug, is not decomposed, and stable and continuous dissolution is possible in vivo, thereby being able to exhibit sufficient efficacy even once a day administration. 본 발명은 미라베그론 또는 그의 약제학적으로 허용되는 염, 이소말트 및 서방화제를 포함하는 방출조절 제제에 관한 것으로, 약물인 미라베그론이 분해되지 않아 장기 보관시 치료효과가 일정하게 유지될 수 있으며, 생체내에서 안정적이면서 지속적인 용출이 가능하여 1일 1회 복용으로도 충분한 약효를 나타낼 수 있는 제제를 개시한다.